6640--Immunoassay CPRR (HIV, HEP, Tacrolimus)
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Materiality: <0.01% of $ABT revenue (Low) SEC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25725Q0416 in this department, oldest first.
- Jun 24, 2025 · this noticeAward NoticeABBOTT LABORATORIES INC. · $1.6M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
Who won similar work
10 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) 6640 and NAICS 334516.
Single-winner award sizes (8): middle half $221K to $528K, median $283K; range $40K to $1.3M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BECKMAN COULTER, INC | 2 | $1.3M | Jan 28, 2026 |
| BECTON, DICKINSON AND COMPANY · $BDX · $19.4B | 1 | $1.3M | Aug 2, 2025 |
| CEPHEID SUNNYVALE 94089 | 1 | $333K | May 15, 2026 |
| AGILENT TECHNOLOGIES, INC. · $A · $6.8B | 1 | $295K | Jul 14, 2026 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 1 | $271K | Feb 18, 2026 |
| ABBOTT LABORATORIES INC. · $ABT · $40.1B | 1 | $238K | Feb 24, 2025 |
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 1 | $40K | Jan 28, 2025 |
| ORTHO-CLINICAL DIAGNOSTICS, INC · $QDEL · $3.0B | 1 | – + 1 shared | May 20, 2025 |
| WERFEN USA LLC | 1 | – + 1 shared | May 15, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $BDX reported $19.4B revenue in FY2025. The median single-winner award in these 8 past awards, $283K, is under 0.1% of that. 10-K
- $A reported $6.8B revenue in FY2025. The median single-winner award in these 8 past awards, $283K, is under 0.1% of that. 10-K
- $ABT reported $40.1B revenue in FY2025. The median single-winner award in these 8 past awards, $283K, is under 0.1% of that. 10-K
- $QDEL reported $3.0B revenue in FY2025. The median single-winner award in these 8 past awards, $283K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Jul 14, 2026AGILENT TECHNOLOGIES, INC.$295K6640--NEW - Seahorse XF Pro Analyzer - Laboratory InstrumentationMateriality: <0.01% of $A revenue (Low) SEC
- May 15, 2026CEPHEID SUNNYVALE 94089$333K6640--Molecular Diagnostic SystemNo listed company matched (Materiality N/A)
- Feb 18, 2026GOVERNMENT SCIENTIFIC SOURCE INC$271K6640--CTX Immunoassay Random Access Multiplex AnalyzerNo listed company matched (Materiality N/A)
- Jan 28, 2026BECKMAN COULTER, INC$1.1M6640--NEW - Automated Hematology CPRR and InstrumentationNo listed company matched (Materiality N/A)
- Sep 16, 2025BECKMAN COULTER, INC$171K6640--STVHCS Microscan MALDI Cost Per TestNo listed company matched (Materiality N/A)
- Aug 2, 2025BECTON, DICKINSON AND COMPANY$1.3M6640--CTX Microbiology Automation SystemMateriality: <0.01% of $BDX revenue (Low) SEC
- May 20, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$334K (shared ceiling)6640--STVHCS - Automated Blood Bank Analyzer - Cost Per TestShared multiple-award ceiling, not one company's win (Materiality N/A)
- May 15, 2025WERFEN USA LLC$334K (shared ceiling)6640--STVHCS - Automated Blood Bank Analyzer - Cost Per TestShared multiple-award ceiling, not one company's win (Materiality N/A)
- Feb 24, 2025ABBOTT LABORATORIES INC.$238K6640--NEW - VCB Automation Line Bridge 3mo+3moMateriality: <0.01% of $ABT revenue (Low) SEC
- Jan 28, 2025POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$40K6640--El Paso Lab OC-Sensor Diana Analyzer - PolymedcoNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (5 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $72K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 4 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.